The expression level of CD133 is elevated in sphere-forming and drug-resistant populations of ovarian cancer cells, which exhibit chemoresistance and tumorigenesis in vivo and increased levels of stemness markers such as OCT4, SOX2, and NANOG [62]. This evidence concerns the gene NANOG and ovarian carcinoma.